Treatment Hypertension to Recommended Levels in Old Patients
Key facts
- Where
- Moscow, RussiaSee the site
Where in Russia
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), University Clinical Hospital No.1, Russian Gerontological Scientific and Clinical CenterMoscow, RussiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- I.M. Sechenov First Moscow State Medical University
- Trial code
- NCT06865846
- Record updated
- 10 March 2025
- Original description
After checking the patient characteristics to the inclusion and exclusion criteria, and confirming the ability to complete the questionnaires provided by the study protocol, patients will be randomly assigned to 2 groups: a group with a higher target BP level (less than 135 mmHg) and a lower target BP level (less than 125 mmHg). Achievement of target BP levels will be assessed using a remote monitoring system. The study will identify factors that prevent achievement of target BP levels, as well as assess the efficacy, safety and tolerability of antihypertensive therapy (AHT).Read full original descriptionShow less
After checking the patient characteristics to the inclusion and exclusion criteria, and confirming the ability to complete the questionnaires provided by the study protocol, patients will be randomly assigned to 2 groups: a group with a higher target BP level (less than 135 mmHg) and a lower target BP level (less than 125 mmHg). Achievement of target BP levels will be assessed using a remote monitoring system. The study will identify factors that prevent achievement of target BP levels, as well as assess the efficacy, safety and tolerability of antihypertensive therapy (AHT).
Inclusion: Men and women aged 65 years and older with hypertension previously diagnosed based on repeated measurements in a medical institution.
Exclusion: Myocardial infarction or stroke within the previous 6 months; Diagnosed dementia or severe cognitive impairment; Presence of hemodynamically significant valvular heart defects; Chronic heart failure with EF ≤ 40%; Presence of severe renal impairment (eGFR <30 ml/min/1.73 m2) and/or increased blood creatinine levels to 221 μmol; Inability to fill in questionnaires specified in the study protocol; Inability to use automatic devices for recording blood pressure at home; Inability to use electronic devices required for remote monitoring of home blood pressure measurements and patient well-being.